Global contract pharmaceutical manufacturing market report scope includes detailed study covering underlying factors influencing the industry trends.
Rising demand for biologics and generic medicines is predicted to primarily drive the contract pharmaceutical manufacturing market size over the forecast time frame. Owing to complex manufacturing requirements and capital-intensive nature of the business, various industry players identified higher profits in developing alliances with CMO i.e. Contract Manufacturing Outsourcing for both commercial and clinical stage production. This will further boost the industry growth from 2018 to 2024.
Global contract pharmaceutical manufacturing market is segregated on the basis of product as, Active Pharmaceutical Ingredient Manufacturing, Finished Dosage Formulation Development & Manufacturing, Secondary Packaging Application. Finished Dosage Formulation Development & Manufacturing is further bifurcated into Solid Dose Formulation, Liquid Dose Formulation, and Injectable Dose Formulation.
In addition, shifting trend of the pharmaceutical industry players toward core competency areas will further add volume to the industry size. Increasing requirement for production technologies together with state-of-the-art processes will prove to be highly effective for meeting regulatory needs. However, prohibited logistics expenses may hinder the contract pharmaceutical market size during the study period.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global contract pharmaceutical manufacturing market share. Major industry players with significant revenue share include Catalent Inc., Recipharm AB, Jubilant Life Sciences Ltd, Patheon Inc., Boehringer Ingelheim, Pfizer Centresource, Aenova, Famar, Baxter Biopharma Solutions, and Lonza.
Global contract pharmaceutical manufacturing market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The contract pharmaceutical manufacturing market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
The report covers:Global contract pharmaceutical manufacturing market sizes from 2015 to 2024, along with CAGR for 2018-2024. Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024 Global contract pharmaceutical manufacturing market trends, covering comprehensive range of consumer trends & manufacturer trends Value chain analysis covering participants from raw material suppliers to the downstream buyer in the contract pharmaceutical manufacturing market Major market opportunities and challenges in forecast timeframe to be focused Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management Comprehensive company profiles of the key industry players
Catalent Inc., Recipharm AB, Jubilant Life Sciences Ltd, Patheon Inc., Boehringer Ingelheim, Pfizer Centresource, Aenova, Famar, Baxter Biopharma Solutions, and Lonza are among the major players in the global contract pharmaceutical manufacturing market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Contract Pharmaceutical Manufacturing Market has been segmented as below:
The Contract Pharmaceutical Manufacturing Marketis segmented on the lines ofContract Pharmaceutical Manufacturing Market, By Service and Contract Pharmaceutical Manufacturing Market, By Region.
Contract Pharmaceutical Manufacturing Market, By Servicethis market is segmented on the basis ofActive Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing its covers Solid Dose Formulation, Liquid Dose Formulation&Injectable Dose Formulation. And Secondary Packaging Application. Contract Pharmaceutical Manufacturing Market, By Regionthis market is segmented on the basis ofNorth America, Europe, Asia Pacific and Rest of World.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
Reasons to Buy this Report:Gain detailed insights on the contract pharmaceutical manufacturing industry trends Find complete analysis on the market status Identify the contract pharmaceutical manufacturing market opportunities and growth segments Analyse competitive dynamics by evaluating business segments & product portfolios Facilitate strategy planning and industry dynamics to enhance decision making
Request Sample Report from here: https://www.marketresearchengine.com/contract-pharmaceutical-manufacturing-market
Table of Contents:Introduction Research Methodology Executive Summary Market Overview
4.2.1. Increasing outsourcing volume by big pharmaceutical industry players
4.2.2. Increasing R&D investment
4.3.1. Stringent regulatory requirements
4.3.2. Increasing lead time and logistics costs
4.4.1. Expansion in the service offering of CMOS
4.4.2. Advent of CDMO Model
4.5.1. Capacity utilization issues affecting the profitability of CMOS Contract Pharmaceutical Manufacturing Market, By Service Competitive Landscape Company Profile
7.1. Catalent Inc.
7.1.1. Company Overview
7.1.2. Product/Service Landscape
7.1.3. Financial Overview
7.1.4. Recent Developments
7.2. Recipharm AB
7.2.1. Company Overview
7.2.2. Product/Service Landscape
7.2.3. Financial Overview
7.2.4. Recent Developments
7.3. Jubilant Life Sciences Ltd
7.3.1. Company Overview
7.3.2. Product/Service Landscape
7.3.3. Financial Overview
7.3.4. Recent Developments
7.4. Patheon Inc.
7.4.1. Company Overview
7.4.2. Product/Service Landscape
7.4.3. Financial Overview
7.4.4. Recent Developments
7.5. Boehringer Ingelheim
7.5.1. Company Overview
7.5.2. Product/Service Landscape
7.5.3. Financial Overview
7.5.4. Recent Developments
7.6. Pfizer Centresource
7.6.1. Company Overview
7.6.2. Product/Service Landscape
7.6.3. Financial Overview
7.6.4. Recent Developments
7.7.1. Company Overview
7.7.2. Product/Service Landscape
7.7.3. Financial Overview
7.7.4. Recent Developments
7.8.1. Company Overview
7.8.2. Product/Service Landscape
7.8.3. Financial Overview
7.8.4. Recent Developments
7.9. Baxter Biopharma Solutions
7.9.1. Company Overview
7.9.2. Product/Service Landscape
7.9.3. Financial Overview
7.9.4. Recent Developments
7.10.1. Company Overview
7.10.2. Product/Service Landscape
7.10.3. Financial Overview
7.10.4. Recent Developments
Other Related Market News :
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States